MediciNova, Inc.
MNOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $123 | $135 | $0 | $0 |
| % Growth | -8.4% | – | – | – |
| Cost of Goods Sold | $162 | $116 | $0 | $5 |
| Gross Profit | -$39 | $18 | $0 | -$5 |
| % Margin | -31.6% | 13.6% | – | – |
| R&D Expenses | $1,536 | $2,189 | $1,740 | $1,907 |
| G&A Expenses | $0 | $1,437 | $1,308 | $1,276 |
| SG&A Expenses | $1,806 | $1,437 | $1,363 | $1,276 |
| Sales & Mktg Exp. | $0 | $0 | $55 | $0 |
| Other Operating Expenses | $0 | $0 | $100 | -$5 |
| Operating Expenses | $3,342 | $3,625 | $3,203 | $3,179 |
| Operating Income | -$3,381 | -$3,607 | -$3,203 | -$3,184 |
| % Margin | -2,741.7% | -2,679.9% | – | – |
| Other Income/Exp. Net | $331 | $326 | $338 | $375 |
| Pre-Tax Income | -$3,050 | -$3,281 | -$2,864 | -$2,809 |
| Tax Expense | $0 | $0 | $0 | $6 |
| Net Income | -$3,050 | -$3,281 | -$2,864 | -$2,815 |
| % Margin | -2,473.6% | -2,437.7% | – | – |
| EPS | -0.06 | -0.067 | -0.058 | -0.057 |
| % Growth | 10.3% | -14.6% | -1.7% | – |
| EPS Diluted | -0.06 | -0.067 | -0.058 | -0.057 |
| Weighted Avg Shares Out | 49,046 | 49,046 | 49,046 | 49,046 |
| Weighted Avg Shares Out Dil | 49,046 | 49,046 | 49,046 | 49,046 |
| Supplemental Information | – | – | – | – |
| Interest Income | $340,850 | $325 | $336 | $390 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $47 | $5 | $5 | $5 |
| EBITDA | -$3,003 | -$3,602 | -$3,197 | -$3,179 |
| % Margin | -2,435.4% | -2,676.1% | – | – |